Medifast, Inc.MEDNYSE
Loading
Gross Profit Over TimeContracting
Percentile Rank50
3Y CAGR-37.7%
5Y CAGR-17.0%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
-37.7%/yr
vs +31.6%/yr prior
5Y CAGR
-17.0%/yr
Recent deceleration
Acceleration
-69.4pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$275.19M-38.1%
2024$444.62M-42.7%
2023$775.85M-32.0%
2022$1.14B+1.1%
2021$1.13B+61.6%
2020$697.82M+30.0%
2019$536.86M+41.3%
2018$379.90M+66.8%
2017$227.81M+10.8%
2016$205.66M-